Search results for "LYMPHOMA"

showing 10 items of 707 documents

Reply to Pich et al.: intrasinusoidal bone marrow infiltration and splenic marginal zone lymphoma: a quantitative study

2006

Pathologymedicine.medical_specialtybone marrowsplenic marginal zone lymphoma.Bone marrow infiltrationbusiness.industryintrasinusoidalHematologyGeneral Medicineinfiltrationmedicine.diseaseMedicineSplenic marginal zone lymphomabusinessEuropean Journal of Haematology
researchProduct

Multiple small bowel perforations during the treatment of primary intestinal extranodal natural killer/T‐cell lymphoma, nasal type

2021

Pathologymedicine.medical_specialtybusiness.industryHematologyNasal typeBowel perforationmedicine.diseaseNatural killer T cellmedicine.disease_causeEpstein–Barr virusLymphomaGastrointestinal perforationmedicinebusinessBritish Journal of Haematology
researchProduct

Pathobiology of Hodgkin Lymphoma

2010

Despite its well-known histological and clinical features, Hodgkin's lymphoma (HL) has recently been the object of intense research activity, leading to a better understanding of its phenotype, molecular characteristics, histogenesis, and possible mechanisms of lymphomagenesis. There is complete consensus on the B-cell derivation of the tumor in most cases, and on the relevance of Epstein-Barr virus infection and defective cytokinesis in at least a proportion of patients. The REAL/WHO classification recognizes a basic distinction between lymphocyte predominance HL (LP-HL) and classic HL (cHL), reflecting the differences in clinical presentation and behavior, morphology, phenotype, and molec…

Pathologymedicine.medical_specialtybusiness.industryMixed cellularityLymphocyteHematologyReview ArticleHistogenesismedicine.diseasePhenotypeVirusLymphomaPathobiologymedicine.anatomical_structurehemic and lymphatic diseasesmedicineHodgkin lymphomaDiseases of the blood and blood-forming organsRC633-647.5businessWho classificationHodgkin lymphoma; microenvironment.Hodgkin lymphomamicroenvironment.Advances in Hematology
researchProduct

Prognostic features of splenic lymphoma with villous lymphocytes

2003

Pathologymedicine.medical_specialtymedicine.anatomical_structurebusiness.industrymedicine.medical_treatmentSplenectomymedicineSplenic lymphoma with villous lymphocytesHematologyBone marrowmedicine.diseasebusinessBritish Journal of Haematology
researchProduct

Re: ?Splenic marginal zone B-cell lymphoma associated with primary Sj�gren?s syndrome?

2003

We describe a 67-year-old woman with primary Sjögren's syndrome who developed a splenic marginal zone B-cell lymphoma, and complained of a dry mouth and Raynaud's phenomenon. She had splenomegaly, swollen lymph nodes and monoclonal IgM-kappa cryoglobulin. After splenectomy, Raynaud's phenomenon had improved with the decrease of cryoglobulin. This is the first case of primary Sjögren's syndrome with splenic marginal zone B-cell lymphoma to be reported.

Pathologymedicine.medical_specialtymedicine.medical_treatmentSplenectomyImmunologyCryoglobulinRheumatologyMedicineHumansB cellAgedbusiness.industrySplenic NeoplasmsLymphoma B-Cell Marginal ZoneGeneral MedicineSwollen lymph nodesmedicine.diseaseMarginal zoneCryoglobulinemiaLymphomaSplenic Neoplasmmedicine.anatomical_structureLymphatic systemSjogren's SyndromeFemalemedicine.symptombusinessHumanClinical Rheumatology
researchProduct

Whole-body magnetic resonance imaging and FDG-PET/CT for lymphoma staging: Assessment of patient experience

2017

Purpose: To compare patient experience of whole-body MRI and FDG-PET/CT performed for lymphoma staging. Methods: One-hundred-fifteen patients (59 males, 56 females; 53 Hodgkin, 62 non-Hodgkin; mean age: 43.8 years) with lymphoma underwent whole-body MRI and FDG-PET/CT for staging and filled a questionnaire regarding their experience of the examinations using a 4-point Likert scale (1, very good; 4,very bad). Differences were evaluated using Wilcoxon signed-rank test. Patients were asked to express their preference on both techniques. Preferences were compared on the basis of gender, age, and Ann Arbor stage using the chi-square test. A p-value ≤ .05 was considered significant. Results: Most…

Patient experiencelcsh:Medical physics. Medical radiology. Nuclear medicinemedicine.medical_specialtyLymphomaWilcoxon signed-rank testlcsh:R895-920Whole body imagingLymphoma staging030218 nuclear medicine & medical imaging03 medical and health sciencesMagnetic resonance imaging0302 clinical medicinePatient experiencemedicineRadiology Nuclear Medicine and imagingStage (cooking)Whole body imagingmedicine.diagnostic_testbusiness.industryMagnetic resonance imagingmedicine.diseaseLymphomaPositron emission tomography030220 oncology & carcinogenesisRadiologyPositron-emission tomographybusinessThe Egyptian Journal of Radiology and Nuclear Medicine
researchProduct

Patient with Kabuki syndrome and acute leukemia

2003

Kabuki syndrome is a multiple congenital anomaly/mental retardation syndrome which often involves recurrent infections. There is cumulative evidence of an immunodeficiency in Kabuki patients. We report a 2-year-old girl with typical Kabuki syndrome, who developed acute lymphocytic leukemia. The patient showed low levels of immunoglobulins G and A and a history of recurrent infections, that might indicate an immunodeficiency leading to an increased susceptibility to cancer. The girl was treated according to BFM protocols adapted to the patient's impaired cardiac situation and severe underweight. She achieved continual complete remission. Classical and molecular cytogenetic analyzes did not d…

Pediatricsmedicine.medical_specialtyAcute leukemiabusiness.industryKabukiInfantCancerPrecursor Cell Lymphoblastic Leukemia-Lymphomamedicine.diseaseIntellectual DisabilityImmunopathologyAcute lymphocytic leukemiaImmunologymedicineHumansAbnormalities MultipleFemaleAbnormalitybusinessKabuki syndromeGenetics (clinical)ImmunodeficiencyAmerican Journal of Medical Genetics
researchProduct

Burkitt’s lymphoma in pregnant woman: Difficult management of a rare case

2020

Highlights • Burkitt’s lymphoma, an aggressive non-Hodgkin lymphoma, is extremely rare during pregnancy. • Lymphoma of the small intestine is often overlooked in the early stages of the disease. • We described a multidisciplinary approach, cesarean section with surgical intestinal exploration.

Pediatricsmedicine.medical_specialtyBurkitt’s lymphomaIntestinal involvementNauseaCase ReportDisease03 medical and health sciences0302 clinical medicineimmune system diseasesPregnancyhemic and lymphatic diseasesmedicineNon-Hodgkin lymphomaPregnancyBurkitt's lymphomabusiness.industryGestational agemedicine.diseaseLymphoma030220 oncology & carcinogenesisVomitingGestation030211 gastroenterology & hepatologySurgerymedicine.symptombusinessBurkitt's lymphomaInternational Journal of Surgery Case Reports
researchProduct

Post-transplant lymphoproliferative disorder in adult renal transplant recipients: case series and review of literature

2021

Post-transplant lymphoproliferative disorder (PTLD) is serious life-threating complication of transplantation. The clinical picture differs from lymphomas observed in the general population, with different manifestation, histopathology, higher aggressiveness with involvement of sites beyond the primary lymph node, and poorer outcome. The objective of the study was to present nine cases of PTLD observed in our centre among the kidney transplant recipient population and discuss the results with up-to-date literature. We performed a retrospective single-centre assessment of PTLD incidence in the cohorts of kidney transplant recipients followed by our centre. We found nine cases of PTLD, five m…

Pediatricsmedicine.medical_specialtyImmunologyPopulationkidney transplantationCase ReportlymphomaPost-transplant lymphoproliferative disorderhemic and lymphatic diseasesImmunology and AllergyMedicineeducationKidney transplantationeducation.field_of_studybusiness.industryIncidence (epidemiology)Rmedicine.diseaseLymphomaTransplantationsurgical procedures operativekidney transplantation.post-transplant lymphoproliferative diseaseMedicinebusinessComplicationRare diseaseCentral European Journal of Immunology
researchProduct

Identification of pyrrolo[3',4':3,4]cyclohepta[1,2-d][1,2]oxazoles as promising new candidates for the treatment of lymphomas

2023

Unsatisfactory outcomes for relapsed/refractory lymphoma patients prompt continuing efforts to develop new therapeutic strategies. Our previous studies on pyrrole-based anti-lymphoma agents led us to synthesize a new series of twenty-six pyrrolo[3′,4':3,4]cyclohepta[1,2-d] [1,2]oxazole derivatives and study their antiproliferative effects against a panel of four non-Hodgkin lymphoma cell lines. Several candidates showed significant anti-proliferative effects, with IC50's reaching the sub-micromolar range in at least one cell line, with compound 3z demonstrating sub-micromolar growth inhibitory effects towards the entire panel. The VL51 cell line was the most sensitive, with an IC50 value of…

Pharmacology2-d][1Antitumor agentsLymphoma4’:3Organic ChemistryGeneral MedicineIsoxazolespyrrolo[3′2]oxazolesHematological malignanciesAntitumor agents; Hematological malignancies; Isoxazoles; Lymphoma; pyrrolo[3′4’:34]cyclohepta[12-d][12]oxazolespyrrolo[3′4’:34]cyclohepta[12-d][12]oxazoles4]cyclohepta[1Drug Discovery
researchProduct